Welcome to the e-CCO Library!

P570: Current status of the effectiveness of infliximab in patients with ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Yokoyama K.*1, Kawagishi K.1, Kobayashi K.2, Koizumi W.1

Created: Wednesday, 20 February 2019, 10:36 AM
P570: Improvements in subcomponents of the inflammatory bowel disease questionnaire in patients treated with vedolizumab: Results from GEMINI trial data
Year: 2018
Source: ECCO '18 Vienna
Authors:

D.T. Rubin1, D. Tudor2, J.M. Khalid3, H. Patel3*

Created: Thursday, 21 February 2019, 9:14 AM
P570: Kock pouches in the 21st century: a descriptive study of short-term (30-day) outcomes in a national cohort of 177 patients
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Shawki1, S. Steele1, J. Lipman1, C. H. A. Lee1, L. Stocchi1, T. Hull1, E. Gorgun1, S. Holubar*1

Created: Friday, 22 February 2019, 9:41 AM
P570: Prediction of achieving remission in Crohn's disease patients by abdominal Imaging
Year: 2021
Source: ECCO'21 Virtual
Authors: Meringer, H.(1);Tzadok, R.(1);Mercer, D.(2);Handler, M.(2);Barnes, S.(2);Waterman, M.(3);Abadi, S.(4);Margalit Yehuda, R.(5);Kopylov, U.(5);Amitai, M.M.(6);Bar-Gil Shitrit, A.(7);Sheynkman, G.(8);Zittan, E.(9);Maharshak, N.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P570: Prevalence and risk factors for intestinal resection in patients with Crohn’s disease in a Greek referral center
Year: 2022
Source: ECCO'22
Authors: Orfanoudaki, E.(1);Foteinogiannopoulou, K.(1);Theodoraki, E.(1);Drygiannakis, I.(1);Romanos, I.(2);Koutroubakis, I.E.(1);
Created: Friday, 11 February 2022, 3:56 PM
P570: Safety and Effectiveness of Tofacitinib in Ulcerative Colitis: Real-world Data from TOFA-UC, a SN-IBD Study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Macaluso, F.S.(1)*;D'Antonio, E.(2);Fries, W.(3);Viola, A.(3);Ksissa, O.(3);Cappello, M.(4);Muscarella, S.(4);Belluardo, N.(5);Giangreco, E.(5);Mocciaro, F.(6);Di Mitri, R.(6);Ferracane, C.(7);Vitello, A.(8);Grova, M.(1);Renna, S.(1);Casà, A.(1);Ventimiglia, M.(9);Orlando, A.(1);
Created: Friday, 14 July 2023, 11:05 AM
P571 Self-Medication with steroids in ulcerative colitis: Results of a patient survey
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. Mesonero Gismero1, I. Rodriguez-Lago2, M. Cañas3, S. Claudia4, R. Saldaña4, L. Feo-Lucas5, S. Fernandez5, L. Cea-Calvo5, B. Juliá5

Created: Thursday, 30 January 2020, 10:12 AM
P571: Can Crohn's colits be cured by surgery?
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Calafiore A., Sgambato D., Rizzello F., Calabrese C., Poggioli G., Laureti S., Calandrini L., Mazza M., Praticò C., Salice M., Campieri M., Gionchetti P.

Created: Wednesday, 20 February 2019, 10:36 AM
P571: Effectiveness and safety of Ustekinumab for induction of remission in patients with Crohn's disease: a multi-centre Israeli study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

A. Bar-Gil Shitrit1, M. Siterman2, M. Waterman3, A. Hirsh4, T. Khoury5, D. Schwartz6, E. Zittan7, J. Adler8, B. Koslowsky1, I. Avni-Biron2, Y. Chowers3, Y. Ron4, E. Israeli5, B. Ungar8, H. Yanai2, N. Maharshak4, S. Ben-Horin8, A. Ben-Ya'acov1, R. Eliakim8, I. Dotan2, E. Goldin1, U. Kopylov8

Created: Friday, 22 February 2019, 9:41 AM
P571: Frequency and risk factors of advanced neoplasia in Korean IBD patients with Low Grade Dysplasia in previous surveillance
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Park, Y.E.(1)*;Kim, D.H.(2);Park, S.K.(3);Lee, Y.J.(4);Lee, C.K.(5);Kim, E.S.(6);Kim, K.O.(7);
Created: Friday, 14 July 2023, 11:05 AM
P571: Optimal biologic management of endoscopic postoperative recurrence following ileocecal resection in Crohn’s disease
Year: 2021
Source: ECCO'21 Virtual
Authors: Bachour, S.(1);Shah, R.(1);Lyu, R.(2);Rieder, F.(1);Cohen, B.(1);Qazi, T.(1);Lashner, B.(1);Achkar, J.P.(1);Philpott, J.(1);Lightner, A.(3);Holubar, S.(3);Regueiro, M.(1);Click , B.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P571: The Nordic diet as a tool to improve the activity of disease and psycho-emotional wellbeing in patients with mild and moderate Ulcerative Colitis – the pilot study.
Year: 2022
Source: ECCO'22
Authors: Birka, I.(1);Girgensone, G.(2);Anspuka, L.(3);Šantare, D.(3);
Created: Friday, 11 February 2022, 3:56 PM
P571: Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC)
Year: 2018
Source: ECCO '18 Vienna
Authors:

S.S.R. Pulusu1*, A. Srinivasan2, K. Krishnaprasad3, D. Cheng4, T. Mogilevski5, E. Flanagan6, C. Keung7, C. Wu8, R. Prosser9, E. Sawyer10, Q.-U.-A. Rizvi11, H. Su12, W.-K. Leung13, A. Edmundson3, S. Cooke14, G. Mahy14, L. Thin15, G. Radford-Smith16, M. Sparrow12, J.M. Andrews11, S. Connor10, P. Bampton17, S. Ghaly8, D. Van Langenberg7, S. Bell6, P. De Cruz5, J. Begun4, S. Ng18, S. Travis2, I. Lawrance1

Created: Thursday, 21 February 2019, 9:14 AM
P572 Clinical outcomes after discontinuation of anti-tumour necrosis factor-α agents in inflammatory bowel disease patients with clinical remission: KASID multicenter study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J.H. Song1, S.M. Kong1, J. Shin1, G. Seong1, E.A. Kang2, S.K. Park3, S.N. Hong1, Y.S. Kim4, K.B. Bang5, K.O. Kim6, H.S. Lee7, S.B. Kang8, S.Y. Shin9, E.M. Song10, C.H. Choi9, T.J. Kim1, E.R. Kim1, D.K. Chang1, Y.H. Kim1

Created: Thursday, 30 January 2020, 10:12 AM
P572: Coexisting Inflammatory bowel disease and Ankylosing spondylitis: Management and clinical outcomes
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Savin, E.(1)*;Levartovsky, A.(2);Gendelman, O.(3);Lidar, M.(3);Ben-Horin, S.(2);Kopylov, U.(2);
Created: Friday, 14 July 2023, 11:05 AM
P572: Half of children with acute severe colitis have predominant single faecal bacterial species, mostly Escherichia coli: Microbiome results from the PRASCO trial
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Bishai1, G. Abitbol2, G. Focht2, M. Schirmer1, D. Marcus2, B. Yerushalmi3, M. Aloi4, A. M. Griffiths5, L. Albenberg1, K-L. Kolho6, S. Cohen7, A. Assa8, A. Levine9, H. Vlamakis1, R. Xavier1, D. Turner*2

Created: Friday, 22 February 2019, 9:41 AM
P572: Medical therapies for stricturing Crohn's disease: efficacy and cross-sectional imaging predictors of therapeutic failure
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Campos C.1, Perrey A.2, Lambert C.3, Pereira B.3, Goutte M.1,4, Goutorbe F.1,5, Dubois A.6, Reymond M.1, Allimant C.1, Dapoigny M.1, Bommelaer G.1,4, Hordonneau C.2, Buisson A.*1,4

Created: Wednesday, 20 February 2019, 10:36 AM
P572: Reactive dose escalation of infliximab in patients with Crohn’s disease in TAILORIX leads to improved outcomes
Year: 2018
Source: ECCO '18 Vienna
Authors:

E. Dreesen1*, D. Laharie2, G. Lambrecht3, P. Bossuyt4, A. Buisson5, J. Filippi6, P. Van Hootegem7, G. D'Haens8, S. Vermeire9,10, A. Gils1

Created: Thursday, 21 February 2019, 9:14 AM
P572: The influence of beliefs about medication in therapeutic adherence among patients with inflammatory bowel disease.
Year: 2021
Source: ECCO'21 Virtual
Authors: De Castro Parga, M.L.(1,2);Alvarez-Smith, C.(1);Sanroman, L.(1);Figueira, M.(1);Hernández, V.(1);Pineda, J.(1);Martinez-Cadilla, J.(1);Pereira, S.(1);Rodriguez-Prada, I.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P572: Therapy optimisation and intravenous ferric carboxymaltose in active or inactive IBD with iron deficiency: it's time to make iron deficiency part of tight monitoring to reach T2T? – preliminary results of a prospective study
Year: 2022
Source: ECCO'22
Authors: Molnár, T.(1);Resál, T.(1);Bacsur, P.(1);Rutka, M.(1);Szántó, K.(1);Bálint, A.(1);Milassin, Á.(1);Fábián, A.(1);Bor, R.(1);Szepes, Z.(1);Farkas, K.(1);
Created: Friday, 11 February 2022, 3:56 PM